Brian Feth is co-founder and CEO of Xcell Biosciences Inc., a San Francisco-based life science company. Brian has led the company through the product development and launch of the Avatar primary cell control platform, focused on regenerative medicine and immunotherapy applications. The company raised a $12M Series A financing round in early 2017. Prior to Xcell, Brian worked with Strategyn Equity Partners, a mid-market private equity firm and with L.E.K. Consulting, a business strategy management consulting firm. Brian earned his Masters of Business Administration from UC Berkeley’s Haas School of Business, his Masters in Bioscience from the Keck Graduate Institute of Applied Sciences, and Bachelor of Science degrees with honors in Molecular Biology and in Chemistry from Purdue University.